TAU Antibody (MAPT)| F43675-0.08ML

TAU Antibody (MAPT)| F43675-0.08ML | Gentaur UK, US & Europe Distribution

Background: MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.

Format: Antigen affinity purified

Clone: N/A

Host Animal: Rabbit

Clonality: Polyclonal (rabbit origin)

Isotype: Rabbit Ig

Species Reactivity: Human

Predicted Spacies Reactivity: Mouse, Rat, Bovine

Application: IHC, WB, ELISA

Application Details: Western blot: 1:1000, IHC (Paraffin): 1:10-1:50

Application Note: Titration of the anti-TAU antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Status: Available

Buffer: N/A

Limitation: This anti-TAU antibody is available for research use only.

Purity: Antigen affinity

Immunogen: A portion of amino acids 699-728 from the human protein was used as the immunogen for this anti-TAU antibody.

Storage: Aliquot the anti-TAU antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Localization: N/A